View in EDS HTML Full Text PDF Full Text

Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022.

Saved in:
Bibliographic Details
Title: Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022.
Authors: Milder TY; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.; Department of Diabetes and Endocrinology, St. Vincent's Hospital, Sydney, Australia.; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia.; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia., Lin J; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Pearson SA; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Greenfield JR; Department of Diabetes and Endocrinology, St. Vincent's Hospital, Sydney, Australia.; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia., Day RO; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia., Stocker SL; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.; School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Australia., Neuen BL; The George Institute for Global Health, University of New South Wales, Sydney, Australia.; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia., Falster MO; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., de Oliveira Costa J; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2025 Jan; Vol. 91 (1), pp. 117-126. Date of Electronic Publication: 2024 Sep 03.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39224963
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Milder+TY%22">Milder TY</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.; Department of Diabetes and Endocrinology, St. Vincent's Hospital, Sydney, Australia.; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia.; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Lin+J%22">Lin J</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Pearson+SA%22">Pearson SA</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Greenfield+JR%22">Greenfield JR</searchLink>; Department of Diabetes and Endocrinology, St. Vincent's Hospital, Sydney, Australia.; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Day+RO%22">Day RO</searchLink>; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Stocker+SL%22">Stocker SL</searchLink>; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.; School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Neuen+BL%22">Neuen BL</searchLink>; The George Institute for Global Health, University of New South Wales, Sydney, Australia.; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Falster+MO%22">Falster MO</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22de+Oliveira+Costa+J%22">de Oliveira Costa J</searchLink>; Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2025 Jan; Vol. 91 (1), pp. 117-126. <i>Date of Electronic Publication: </i>2024 Sep 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39224963
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bcp.16231
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 117
    Titles:
      – TitleFull: Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Milder TY
      – PersonEntity:
          Name:
            NameFull: Lin J
      – PersonEntity:
          Name:
            NameFull: Pearson SA
      – PersonEntity:
          Name:
            NameFull: Greenfield JR
      – PersonEntity:
          Name:
            NameFull: Day RO
      – PersonEntity:
          Name:
            NameFull: Stocker SL
      – PersonEntity:
          Name:
            NameFull: Neuen BL
      – PersonEntity:
          Name:
            NameFull: Falster MO
      – PersonEntity:
          Name:
            NameFull: de Oliveira Costa J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2125
          Numbering:
            – Type: volume
              Value: 91
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: British journal of clinical pharmacology
              Type: main
ResultId 1